Asymmetric cleavage of β-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses

被引:98
|
作者
Ziouzenkova, Ouliana
Orasanu, Gabriela
Sukhova, Galina
Lau, Evan
Berger, Joel P.
Tang, Guangwen
Krinsky, Norman I.
Dolnikowski, Gregory G.
Plutzky, Jorge
机构
[1] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[2] Merck Res Labs, Rahway, NJ USA
[3] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Medford, MA 02155 USA
[4] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
关键词
D O I
10.1210/me.2006-0225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
beta-Carotene and its metabolites exert a broad range of effects, in part by regulating transcriptional responses through specific nuclear receptor activation. Symmetric cleavage of beta-carotene can yield 9-cis retinoic acid (9-cisRA), the natural ligand for the nuclear receptor RXR, the obligate heterodimeric partner for numerous nuclear receptor family members. A significant portion of beta-carotene can also undergo asymmetric cleavage to yield apocarotenals, a series of poorly understood naturally occurring molecules whose biologic role, including their transcriptional effects, remains essentially unknown. We show here that beta-apo-14'-carotenal (apo14), but not other structurally related apocarotenals, represses peroxisome proliferator-activated receptors (PPAR) and RXR activation and biologic responses induced by their respective agonists both in vitro and in vivo. During adipocyte differentiation, apo14 inhibited PPAR gamma target gene expression and adipogenesis, even in the presence of the potent PPAR gamma agonist BRL49653. Apo14 also suppressed known PPAR alpha responses, including target gene expression and its known antiinflammatory effects, but not if PPAR alpha agonist stimulation occurred before apo14 exposure and not in PPAR alpha-deficient cells or mice. Other apocarotenals tested had none of these effects. These data extend current views of beta-carotene metabolism to include specific apocarotenals as possible biologically active mediators and identify apo14 as a possible template for designing PPAR and RXR modulators and better understanding modulation of nuclear receptor activation. These results also suggest a novel model of molecular endocrinology in which metabolism of a parent compound, beta-carotene, may alternatively activate (9-cisRA) or inhibit (apo14) specific nuclear receptor responses.
引用
收藏
页码:77 / 88
页数:12
相关论文
共 50 条
  • [21] Peroxisome proliferator-activated receptor γ and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles
    Ray, Denise M.
    Spinelli, Sherry L.
    Pollock, Stephen J.
    Murant, Thomas I.
    O'Brien, Jamie J.
    Blumberg, Neil
    Francis, Charles W.
    Taubman, Mark B.
    Phipps, Richard P.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (01) : 86 - 95
  • [22] Peroxisome proliferator-activated receptor agonists
    Willson, TM
    Wahli, W
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) : 235 - 241
  • [23] Peroxisome proliferator-activated receptor γ and cancers
    Koeffler, HP
    CLINICAL CANCER RESEARCH, 2003, 9 (01) : 1 - 9
  • [24] Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
    Nishida, K.
    Kunisada, T.
    Shen, Z. N.
    Kadota, Y.
    Hashizume, K.
    Ozaki, T.
    PPAR RESEARCH, 2008, 2008
  • [25] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Nikolaus Marx
    Current Hypertension Reports, 2002, 4 : 71 - 77
  • [26] Role of the peroxisome proliferator-activated receptor α in responses to dilsononyl phthalate
    Valles, EG
    Laughter, AR
    Dunn, CS
    Cannelle, S
    Swanson, CL
    Cattley, RC
    Corton, JC
    TOXICOLOGY, 2003, 191 (2-3) : 211 - 225
  • [27] Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
    Jean-Charles Fruchart
    Cardiovascular Diabetology, 12
  • [29] Combination therapy with retinoid X receptor and peroxisome proliferator-activated receptor gamma agonists for cutaneous T cell lymphoma
    DuBois, RN
    Gupta, RA
    Zic, JA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A55 - A55
  • [30] Peroxisome proliferator-activated receptor α-mediated pathways are altered in hepatocyte-specific retinoid X receptor α-deficient mice
    Wan, YJY
    Cai, Y
    Lungo, W
    Fu, P
    Locker, J
    French, S
    Sucov, HM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (36) : 28285 - 28290